Clinical Trial Update: Acceptability of a New Paediatric Formulation of Hydroxycarbamide in Children With Sickle Cell Disease. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating acceptability of a new paediatric formulation of hydroxycarbamide in children with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Hydroxycarbamide (hydroxycarbamide)

Snippet

Sponsor: Theravia | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED